Compare PASG & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PASG | GOCO |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United States | United States |
| Employees | 24 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2M | 17.7M |
| IPO Year | 2020 | 2020 |
| Metric | PASG | GOCO |
|---|---|---|
| Price | $5.62 | $0.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $14.00 | $4.75 |
| AVG Volume (30 Days) | 43.6K | ★ 122.4K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $361,845,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $77.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.35 | $0.60 |
| 52 Week High | $20.00 | $6.61 |
| Indicator | PASG | GOCO |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 32.15 |
| Support Level | $4.97 | $0.60 |
| Resistance Level | $7.77 | $2.53 |
| Average True Range (ATR) | 0.31 | 0.09 |
| MACD | 0.18 | 0.02 |
| Stochastic Oscillator | 75.45 | 20.23 |
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions, so it can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. The proprietary technology platform integrates artificial intelligence and modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.